Water Island Capital’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Water Island Capital’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-22,500	Closed	-$15K	–	89
2019 Q3	$15K	Buy	+22,500	New	+$90K	﹤0.01%	76

Water Island Capital's PRTK Position: Q3 2023 in Review

Water Island Capital sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 84,697 shares — an estimated $187K sold.

Water Island Capital first reported a position in PRTK in Q3 2017 and held it in 23 quarters. The position peaked at $4.26M in Q3 2018. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Water Island Capital reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Water Island Capital sold 84,697 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $187K.
Water Island Capital first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2017 and held it in 23 quarters.
Water Island Capital's Paratek Pharmaceuticals, Inc. position peaked at $4.26M in Q3 2018.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Water Island Capital's 13F filing for Q3 2023, filed 14 Nov 2023.